HEATHER ROSARIO: Open Payments
NPI 1841694726 · ABINGDON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,295 in 176 payments from 22 companies in 2025. Trend: 2023 $2,010 · 2024 $2,924 · 2025 $12,295
Consulting: $5,509Food & beverage: $5,356Travel & lodging: $1,331Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 39 | $3,862 |
| Genentech USA, Inc. | 6 | $3,081 |
| ABBVIE INC. | 51 | $1,842 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $1,777 |
| Phathom Pharmaceuticals, Inc. | 18 | $347 |
| Madrigal Pharmaceuticals | 10 | $299 |
| PFIZER INC. | 8 | $201 |
| Ardelyx, Inc. | 3 | $147 |
| Enterra Medical, Inc. | 1 | $109 |
| Mallinckrodt Hospital Products Inc. | 3 | $87 |
Products named: TREMFYA, RINVOQ, ENTYVIO, SKYRIZI, VOQUEZNA, REZDIFFRA, CREON, VELSIPITY.
Industry payments across MD — which companies pay providers there.
